首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1942726篇
  免费   193882篇
  国内免费   1918篇
  2138526篇
  2021年   18773篇
  2018年   20727篇
  2017年   19525篇
  2016年   30514篇
  2015年   44092篇
  2014年   52326篇
  2013年   78587篇
  2012年   57407篇
  2011年   51184篇
  2010年   51036篇
  2009年   50156篇
  2008年   46293篇
  2007年   46078篇
  2006年   47087篇
  2005年   48048篇
  2004年   46881篇
  2003年   43884篇
  2002年   41796篇
  2001年   66030篇
  2000年   64514篇
  1999年   55937篇
  1998年   29542篇
  1997年   29496篇
  1996年   28290篇
  1995年   26507篇
  1994年   26026篇
  1993年   25622篇
  1992年   47763篇
  1991年   46079篇
  1990年   44675篇
  1989年   44555篇
  1988年   41440篇
  1987年   39337篇
  1986年   37096篇
  1985年   38396篇
  1984年   34513篇
  1983年   29998篇
  1982年   26664篇
  1981年   24974篇
  1980年   23501篇
  1979年   31162篇
  1978年   26546篇
  1977年   24954篇
  1976年   23505篇
  1975年   24406篇
  1974年   25884篇
  1973年   26008篇
  1972年   22968篇
  1971年   20972篇
  1970年   18421篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
We have identified mouse and human FKBP60, a new member of the FKBP gene family. FKBP60 shares strongest homology with FKBP65 and SMAP. FKBP60 contains a hydrophobic signal peptide at the N-terminus, 4 peptidyl-prolyl cis/trans isomerase (PPIase) domains and an endoplasmic reticulum retention motif (HDEL) at the C-terminus. Immunodetection of HA-tagged FKBP60 in NIH-3T3 cells suggests that FKBP60 is segregated to the endoplasmic reticulum. Northern blot analysis shows that FKBP60 is predominantly expressed in heart, skeletal muscle, lung, liver and kidney. With N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide as a substrate, recombinant GST-FKBP60 is shown to accelerate effectively the isomerization of the peptidyl-prolyl bond. This isomerization activity is inhibited by FK506. mFKBP60 binds Ca2+ in vitro, presumably by its C-terminal EF-hand Ca2+ binding motif, and is phosphorylated in vivo. hFKBP60 has been mapped to 7p12 and/or 7p14 by fluorescence in situ hybridization (FISH).  相似文献   
3.
4.
Squilla mantis hemocyanin is composed of two hexameric subunits but has electron microscopic profiles different from other bis-hexameric hemocyanins, e.g. Astacus and Homarus. We distinguished three different electron microscopic profiles of S. mantis hemocyanin: two sideviews and a topview. These profiles were studied using computer image alignment and correspondence analysis [Van Heel, M. and Frank, J. (1981) Ultramicroscopy 6, 187 - 194]. With the results of this analysis we were able to build a three-dimensional model for the quaternary structure of this hemocyanin. In this model the two hexamers are stacked in such a way that their hexagonal surfaces overlap to about 60% of their width. In the overlap area four subunits are arranged in two different interhexameric pairs, each forming a bridging area between the two hexamers.  相似文献   
5.
6.
7.
A patient with chronic anemia is presented who radiologically showed prominent rugae of the stomach. Angiography demonstrated an arteriovenous malformation with a large feeding artery and prominent draining veins.  相似文献   
8.
9.
10.
Conventional therapies for prostate cancer, especially in its androgen-independent form, may result in the survival of small populations of resistant cells with tumor-initiating potential. These “cancer stem cells” are believed to be responsible for cancer relapse, and therapeutic strategies targeting these cells are of great importance. Telomerase is a ribonucleoprotein enzyme responsible for telomere elongation and is activated in the majority of malignancies, including prostate cancer, but is absent in most normal cells. Putative tumor-initiating cells have significant levels of telomerase, indicating that they are an excellent target for telomerase inhibition therapy. In this review, we present some evidence for the hypothesis that conventional therapies (standard chemotherapy and/or radiation therapy) in combination with telomerase inhibitors may result in effective and more durable responses.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号